UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A MALT lymphoma prognostic index

Blood, 2017-09, Vol.130 (12), p.1409-1417

2017

Volltextzugriff (PDF)

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study

Journal of clinical oncology, 2013-02, Vol.31 (5), p.565-572

2013

Volltextzugriff (PDF)

Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization

Expert opinion on biological therapy, 2014-06, Vol.14 (6), p.757-772

2014

Volltextzugriff (PDF)

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3494-3499

2023

Volltextzugriff (PDF)

Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1979-1983

2005

Volltextzugriff (PDF)

Disposal of the residual autologous HSC units: Results of a survey carried out two years after the publication of a national policy in Italy

Transfusion and apheresis science, 2018-04, Vol.57 (2), p.197-200

2018

Volltextzugriff (PDF)

Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2233-2238

2010

Volltextzugriff (PDF)

Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3675-3684

2001

Volltextzugriff (PDF)

Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres

Blood transfusion = Trasfusione del sangue, 2012-10, Vol.10 (4), p.440-447

2012

Volltextzugriff (PDF)

Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis

Seminars in oncology, 2023-02, Vol.50 (1-2), p.34-39

2023

Volltextzugriff (PDF)

Midline catheter as effective device in healthy allogeneic donors and patients without an adequate peripheral venous access for HPC collection by apheresis: Preliminary experience at IEO

Transfusion and apheresis science, 2020-06, Vol.59 (3), p.102740-102740, Article 102740

2020

Volltextzugriff (PDF)

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

Journal of clinical oncology, 2016-02, Vol.34 (5), p.495-500

2016

Volltextzugriff (PDF)

Plerixafor: what we still have to learn

Expert opinion on biological therapy, 2015-02, Vol.15 (2), p.143-147

2015

Volltextzugriff (PDF)

Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma

Transfusion (Philadelphia, Pa.), 2014-02, Vol.54 (2), p.331-339

2014

Volltextzugriff (PDF)

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity‐score weighted multicenter approach

American journal of hematology, 2017-09, Vol.92 (9), p.E557-E559

2017

Volltextzugriff (PDF)

A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease

American journal of clinical pathology, 1999-12, Vol.112 (6), p.791-800

1999

Volltextzugriff (PDF)

"Fludarabine Containing-Regimens May Adversely Affect Peripheral Blood Stem Cell Collection in Low-Grade Non Hodgkin Lymphoma Patients"

Leukemia & lymphoma, 2000, Vol.37 (1-2), p.157-161

2000

Volltextzugriff (PDF)

Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study

Hematological oncology, 2015-12, Vol.33 (4), p.129-135

2015

Volltextzugriff (PDF)

Plerixafor and Filgrastim XM02 (Tevagastrim®) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation

European journal of haematology, 2012-02, Vol.88 (2), p.154-158

2012

Volltextzugriff (PDF)

Core needle biopsy as a front line diagnostic approach for lymphoma patients

Hematological oncology, 2015-12, Vol.33 (4), p.247-249

2015

Volltextzugriff (PDF)

Who should be really considered as a poor mobilizer in the plerixafor era?

Transfusion and apheresis science, 2012-08, Vol.47 (1), p.27-32

2012

Volltextzugriff (PDF)

R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma

Transfusion and apheresis science, 2014-06, Vol.50 (3), p.411-414

2014

Volltextzugriff (PDF)

Salvage high-dose chemotherapy for relapsed pure seminoma in the last 10 years: results from the European Society for Blood and Marrow Transplantation series 2002-2012

Clinical genitourinary cancer, 2017-02, Vol.15 (1), p.163-167

2017

Volltextzugriff (PDF)

Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: A case report

Transfusion and apheresis science, 2013-10, Vol.49 (2), p.205-207

2013

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaRisk Assessment

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Humans
(54)
Science & Technology
(53)
Life Sciences & Biomedicine
(48)
Male
(37)
Female
(35)
Middle Aged
(29)
Adult
(27)
Hematology
(26)
Aged
(22)
Oncology
(18)
Treatment Outcome
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Retrospective Studies
(10)
Hematopoietic Stem Cell Mobilization - Methods
(8)
Adolescent
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(7)
Rituximab
(7)
Drug Administration Schedule
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A MALT lymphoma prognostic index

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study

Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy

Disposal of the residual autologous HSC units: Results of a survey carried out two years after the publication of a national policy in Italy

Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study

Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation

Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres

Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis

Midline catheter as effective device in healthy allogeneic donors and patients without an adequate peripheral venous access for HPC collection by apheresis: Preliminary experience at IEO

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

Plerixafor: what we still have to learn

Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo

Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity‐score weighted multicenter approach

A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease

"Fludarabine Containing-Regimens May Adversely Affect Peripheral Blood Stem Cell Collection in Low-Grade Non Hodgkin Lymphoma Patients"

Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study

Plerixafor and Filgrastim XM02 (Tevagastrim®) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation

Core needle biopsy as a front line diagnostic approach for lymphoma patients

Who should be really considered as a poor mobilizer in the plerixafor era?

R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma

Salvage high-dose chemotherapy for relapsed pure seminoma in the last 10 years: results from the European Society for Blood and Marrow Transplantation series 2002-2012

Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: A case report

Aktive Filter

Suchergebnisse filtern